- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cencora Inc (COR)Cencora Inc stock price live, this page displays NYSE COR stock exchange data. View the COR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cencora Inc real time stock price chart below.
What Is the Cencora Inc Stock Price Today?
The Cencora Inc stock price today is 232.12.
What Is the Stock Symbol for Cencora Inc?
The stock symbol for Cencora Inc is ""COR.""
What Stock Exchange Does Cencora Inc Trade On?
Cencora Inc is listed and trades on the NYSE stock exchange.
Is Cencora Inc a Good Stock to Buy?
Determining whether Cencora Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COR quote. (ISIN: US03073E1055)
What Is the Cencora Inc Stock Price Today?
The Cencora Inc stock price today is 232.12.
What Is the Stock Symbol for Cencora Inc?
The stock symbol for Cencora Inc is ""COR.""
What Stock Exchange Does Cencora Inc Trade On?
Cencora Inc is listed and trades on the NYSE stock exchange.
Is Cencora Inc a Good Stock to Buy?
Determining whether Cencora Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the COR quote. (ISIN: US03073E1055)
232.12
+0.23(+0.10%)
Closed
Pre Market
232.51+0.39(+0.17%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
231.04
234.63
52 wk Range
196.63
253.27
COR Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
231.04234.63
52 wk Range
196.63253.27
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.95%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.95%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
267.14
Upside
+15.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 20 consecutive years
- Cencora Closes $1.8 Billion Senior Notes Offering
- Investing.com
- Amerisourcebergn receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Amerisourcebergn receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Cencora Closes $1.8 Billion Senior Notes Offering
- Investing.com
- Amerisourcebergn receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mizuho sets Cencora Outperform with $280 target
- Investing.com
Cencora Inc Company Profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Cencora Inc SWOT Analysis
Specialty Powerhouse | Cencora's leading position in specialty pharmaceuticals and strategic acquisitions position it for growth in high-margin markets |
Financial Resilience | Robust U.S. Healthcare performance drives EPS guidance increase, with analysts projecting $13.65 for FY24 and $14.67 for FY25 |
Market Dynamics | Explore how Cencora navigates evolving retail pharmacy landscape and GLP-1 drug trends, balancing opportunities with potential challenges |
Analyst Outlook | Delve into varied analyst perspectives, with price targets ranging from $263 to $290, reflecting confidence in Cencora's market position |
COR Full Pro Research
Institutional-Grade Stock Analysis
Understand how COR earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Cencora Inc Earnings Call Summary for Q4/2024
- Q4 adjusted EPS up 17% YoY to $3.34; revenue rose 15% to $79.1B; US Healthcare Solutions revenue up 16%, driven by 55% surge in GLP-1 sales
- Acquired Retina Consultants of America, expected to be $0.35 accretive in first year; aligns with strategic focus on specialty pharmaceuticals
- FY2025 guidance: adjusted EPS $14.80-$15.10 (8-10% growth); revenue growth 7-9%; operating income growth 5-6.5%
- International segment saw 6% revenue growth but 9% drop in operating income; company anticipates headwinds from COVID-related products
- CEO defends MSO model amid regulatory scrutiny; emphasizes benefits for community providers and healthcare cost-effectiveness
Last Updated: 06/11/2024, 19:40
Read Full TranscriptCompare COR to Peers and Sector
Metrics to compare | COR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCORPeersSector | |
|---|---|---|---|---|
P/E Ratio | 29.7x | 19.5x | −0.6x | |
PEG Ratio | −2.53 | −1.96 | 0.00 | |
Price/Book | 69.5x | 8.8x | 2.6x | |
Price / LTM Sales | 0.2x | 2.5x | 3.2x | |
Upside (Analyst Target) | 12.1% | 14.2% | 45.4% | |
Fair Value Upside | Unlock | 20.4% | 7.7% | Unlock |
Analysts' Recommendations
9 Buy
7 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 267.14
(+15.09% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.6
Dividend Yield
0.95%
Industry Median 0.73%
Annualised payout
2.2000
Paid quarterly
5-Years Growth
+4.98%
Growth Streak
People Also Watch
FAQ
What Is the Cencora Inc (COR) Premarket Price Today?
The Cencora Inc (COR) premarket price is . Premarket price change units: . Premarket percentage change: . Premarket volume: . Current date: 13 Dec 2024. Previous close: 232.12
What Stock Exchange Does Cencora Inc Trade On?
Cencora Inc is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Cencora Inc?
The stock symbol for Cencora Inc is "COR."
What Is the Cencora Inc (COR) Afterhours Price Today? (Afterhours variable test: ) Current Date: 13 Dec 2024
After hours price: . After hours price change (units): . Price change percentage:
What Is the Cencora Inc Market Cap?
As of today, Cencora Inc market cap is 44.85B.
What is Cencora Inc Earnings Per Share?
The Cencora Inc EPS is 7.60.
What Is the Next Cencora Inc Earnings Date?
Cencora Inc will release its next earnings report on 29 Jan 2025.
From a Technical Analysis Perspective, Is COR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.